Balance Sheet

  • Company Name :
Remus Pharmaceuticals Ltd Industry : Pharmaceuticals
  • BSE Code:
  • -
  • NSE Symbol:
  • REMUS
  • P/E(TTM):
  • 41.29
  • ISIN Demat:
  • INE0O5T01011
  • Div & Yield%:
  • 0.22
  • EPS(TTM):
  • 16.76
  • Book Value(₹):
  • 205.55
  • Market Cap(₹Cr.):
  • 815.45
  • Face Value(₹):
  • 10.00
  Mar'2025 Mar'2024 Mar'2023 Mar'2022 Mar'2021
SOURCES OF FUNDS :          
Equity Share Capital 5.89 1.47 1.09 1.00 0.01
Reserves 236.33 152.08 18.05 5.58 3.13
Equity Share Warrants 0.00 0.00 0.00 0.00 0.00
Equity Application Money 0.00 0.00 0.00 0.00 0.00
Total Shareholders Funds 242.22 153.55 19.14 6.58 3.14
Secured Loans 2.50 1.65 2.30 0.19 0.28
Unsecured Loans 1.81 2.47 5.65 0.00 0.00
Total Debt 4.31 4.12 7.95 0.19 0.28
Other Liabilities 0.67 0.46 0.28 0.00 0.00
Total Liabilities 247.20 158.13 27.37 6.77 3.42
APPLICATION OF FUNDS :          
Gross Block 10.51 7.14 3.50 0.79 0.72
Less: Accumulated Depreciation 3.50 2.08 0.96 0.48 0.33
Less:Impairment of Assets 0.00 0.00 0.00 0.00 0.00
Net Block 7.01 5.06 2.54 0.31 0.39
Lease Adjustments 0.00 0.00 0.00 0.00 0.00
Capital Work in Progress 0.06 0.01 0.02 0.00 0.00
Investments 208.80 126.94 20.62 3.07 0.07
Current Assets, Loans & Advances          
Inventories 2.12 1.89 0.29 1.59 1.15
Sundry Debtors 15.63 14.60 4.85 2.92 3.60
Cash and Bank Balance 4.37 10.84 3.04 1.15 0.83
Loans and Advances 31.79 21.55 3.17 2.04 1.91
Total Current Assets 53.91 48.88 11.34 7.70 7.50
Less : Current Liabilities and Provisions          
Current Liabilities 9.91 13.21 6.40 8.61 7.18
Provisions 0.30 0.99 0.91 0.48 0.41
Total CL & Provisions 10.21 14.20 7.31 9.09 7.59
Net Current Assets 43.70 34.68 4.03 -1.40 -0.10
Miscellaneous Expenses not written off 0.00 0.00 0.00 0.00 0.00
Deferred Tax Assets 0.00 0.00 0.13 0.04 0.03
Deferred Tax Liability 22.90 11.16 0.00 0.00 0.00
Net Deferred Tax -22.90 -11.16 0.13 0.04 0.03
Other Assets 10.53 2.60 0.01 4.75 3.03
Total Assets 247.20 158.13 27.35 6.77 3.42
Contingent Liabilities 0.00 75.35 94.36 0.00 0.00